{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:49:06Z","timestamp":1790866146786,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.ygyno.2008.04.012","type":"journal-article","created":{"date-parts":[[2008,6,3]],"date-time":"2008-06-03T15:32:37Z","timestamp":1212507157000},"page":"179-184","source":"Crossref","is-referenced-by-count":44,"title":["Human papillomavirus genotype distribution in low-grade squamous intraepithelial lesions in France and comparison with CIN2\/3 and invasive cervical cancer"],"prefix":"10.1016","volume":"110","author":[{"given":"Jean-Luc","family":"Pr\u00e9tet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Carole","family":"Jacquard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u00eblle","family":"Saunier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Clavel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Dachez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Gondry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Pradat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beno\u00eet","family":"Soubeyrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yann","family":"Leocmach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Mougin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Riethmuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2008.04.012_bib1","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/01.ogx.0000221010.82943.8c","article-title":"Human papillomavirus: the burden of infection","volume":"61","author":"Wiley","year":"2006","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.ygyno.2008.04.012_bib2","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jadohealth.2005.09.011","article-title":"Impact of HPV infection in adolescent populations","volume":"37","author":"Moscicki","year":"2005","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.ygyno.2008.04.012_bib3","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0029-7844(98)00245-2","article-title":"Natural history of cervical squamous intraepithelial lesions: a meta-analysis","volume":"92","author":"Melnikow","year":"1998","journal-title":"Obstet Gynecol"},{"issue":"Suppl","key":"10.1016\/j.ygyno.2008.04.012_bib4","doi-asserted-by":"crossref","first-page":"40470","DOI":"10.1155\/IDOG\/2006\/40470","article-title":"Epidemiology and natural history of human papillomavirus infections in the female genital tract","author":"Ault","year":"2006","journal-title":"Infect Dis Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2008.04.012_bib5","first-page":"4","article-title":"Management of abnormal smears intraepithelial neoplasia and associated treatment costs in France.","volume":"1","author":"Bergeron","year":"2007","journal-title":"Bull Epidemiol Hebd"},{"key":"10.1016\/j.ygyno.2008.04.012_bib6","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/sj.bjc.6603469","article-title":"High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6\/11\/16\/18 L1 virus-like particle vaccine through 5\u00a0years of follow-up","volume":"95","author":"Villa","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ygyno.2008.04.012_bib7","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0140-6736(06)68181-6","article-title":"Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis","volume":"367","author":"Kyrgiou","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2008.04.012_bib8","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.1016\/j.vaccine.2007.03.049","article-title":"Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6\/11\/16\/18 L1 virus-like particle (VLP) vaccine","volume":"25","author":"Olsson","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.ygyno.2008.04.012_bib9","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ijc.23093","article-title":"Human papillomavirus genotype distribution in high grade cervical lesions (CIN 2\/3) in France: EDITH study","volume":"122","author":"Pretet","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2008.04.012_bib10","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/ijc.23092","article-title":"Human papillomavirus (HPV) genotype distribution in invasive cervical cancers in France: EDITH study.","volume":"122","author":"Pretet","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2008.04.012_bib11","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"Munoz","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ygyno.2008.04.012_bib12","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1158\/1055-9965.EPI-04-0812","article-title":"Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer","volume":"14","author":"Clifford","year":"2005","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.ygyno.2008.04.012_bib13","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/00007435-200307000-00010","article-title":"Occurrence of cervical infection with multiple human papillomavirus types is associated with age and cytologic abnormalities","volume":"30","author":"Rousseau","year":"2003","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.ygyno.2008.04.012_bib14","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/sj.bjc.6603653","article-title":"High-risk HPV type-specific clearance rates in cervical screening","volume":"96","author":"Bulkmans","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ygyno.2008.04.012_bib15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/sj.bjc.6603843","article-title":"HPV type-specific risks of high-grade CIN during 4\u00a0years of follow-up: a population-based prospective study","volume":"97","author":"Naucler","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ygyno.2008.04.012_bib16","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1086\/427557","article-title":"Development and duration of human papillomavirus lesions, after initial infection","volume":"191","author":"Winer","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ygyno.2008.04.012_bib17","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/jnci\/91.3.252","article-title":"Natural history of dysplasia of the uterine cervix","volume":"91","author":"Holowaty","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2008.04.012_bib18","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1086\/426867","article-title":"A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women","volume":"191","author":"Brown","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ygyno.2008.04.012_bib19","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/oxfordjournals.jncimonographs.a003487","article-title":"Chapter 12: human papillomavirus technologies","author":"Iftner","year":"2003","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.ygyno.2008.04.012_bib20","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1128\/JCM.37.8.2508-2517.1999","article-title":"Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus","volume":"37","author":"Kleter","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ygyno.2008.04.012_bib21","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/jmv.10220","article-title":"Comparisons of HPV DNA detection by MY09\/11 PCR methods","volume":"68","author":"Castle","year":"2002","journal-title":"J Med Virol"},{"key":"10.1016\/j.ygyno.2008.04.012_bib22","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(04)17398-4","article-title":"Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial","volume":"364","author":"Harper","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2008.04.012_bib23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1470-2045(05)70101-7","article-title":"Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial","volume":"6:","author":"Villa","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ygyno.2008.04.012_bib24","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa061741","article-title":"Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions","volume":"356","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ygyno.2008.04.012_bib25","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0140-6736(07)60852-6","article-title":"Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials","volume":"369","author":"Ault","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2008.04.012_bib26","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/S0140-6736(07)60946-5","article-title":"Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial","volume":"369","author":"Paavonen","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2008.04.012_bib27","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/jnci\/dji187","article-title":"The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice","volume":"97","author":"Khan","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2008.04.012_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2007.05.005","article-title":"E7 properties of mucosal human papillomavirus types 26, 53 and 66 correlate with their intermediate risk for cervical cancer development","volume":"367","author":"Mansour","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.ygyno.2008.04.012_bib29","series-title":"French National Authority for Health. Practice guidelines. Management of a patient with an abnormal cervical smear","author":"ANAES","year":"2002"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825808002813?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825808002813?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T15:07:11Z","timestamp":1738249631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825808002813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S0090825808002813"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2008.04.012","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}